Moreover, the restoration of hsa-miR34a reduces cell viability, promotes apoptosis and enhances sorafenib-induced apoptosis and toxicity in HCC via inhibiting BCL2 expression54. This evidence concerns the gene BCL2 and hepatocellular carcinoma.